Primary Normal Human Skeletal Myoblasts (HSkM) are designed to undergo highly efficient differentiation following plating of cryopreserved cells.
The cells are:
• Performance tested—guaranteed to differentiate ≥ 50% following 48 hours of incubation
• Guaranteed to be ≥ 70% viable
• Tested for mycoplasma, bacteria, yeast or other fungi, hepatitis B, hepatitis C, and HIV-1 viruses
Each vial contain sufficient number of cells to fully seed a single multi-well dish (ranging in format from 6-well to 384-well).